Cynthia R Giver

Cynthia R Giver

UNVERIFIED PROFILE

Are you Cynthia R Giver?   Register this Author

Register author
Cynthia R Giver

Cynthia R Giver

Publications by authors named "Cynthia R Giver"

Are you Cynthia R Giver?   Register this Author

20Publications

446Reads

6Profile Views

A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells.

Biol Blood Marrow Transplant 2018 12 5;24(12):2373-2380. Epub 2018 Jul 5.

Department of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.06.035DOI Listing
December 2018

Host bone marrow-derived IL-12 enhances donor T cell engraftment in a mouse model of bone marrow transplantation.

J Hematol Oncol 2014 Feb 28;7:16. Epub 2014 Feb 28.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 1365B Clifton Rd, NE, Room B5119, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-8722-7-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996069PMC
February 2014

IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.

Blood 2012 Jan 30;119(4):1075-85. Epub 2011 Nov 30.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University Medical School, 1365B Clifton Road NE, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-12-322891DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271719PMC
January 2012

Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

Immunotherapy 2009 Jul;1(4):599-621

Department of Hematology/Oncology, Emory University School of Medicine, Winship Cancer Institute, 1365C Clifton Road NE, Room C4002, Atlanta, GA 3032, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827928PMC
http://dx.doi.org/10.2217/imt.09.32DOI Listing
July 2009

Graft engineering using ex vivo methods to limit GVHD: fludarabine treatment generates superior GVL effects in allogeneic BMT.

Exp Hematol 2006 Jul;34(7):895-904

Emory University, Winship Cancer Institute, Hematology/Oncology, Atlanta, Ga., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2006.03.008DOI Listing
July 2006

Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.

Blood Cells Mol Dis 2004 Nov-Dec;33(3):233-7

Division of Hematology-Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2004.08.009DOI Listing
April 2005

Reconstructing immunity after allogeneic transplantation.

Immunol Res 2004 ;29(1-3):269-82

Blood Cell Therapy Laboratory, Winship Cancer Institute, Emory University, 1365C Clifton Road, Rm. 4002, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/IR:29:1-3:269DOI Listing
December 2004

Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.

Biol Blood Marrow Transplant 2003 Oct;9(10):616-32

Hematology/Oncology Department, Winship Cancer Institute, Emory University, 1639 Pierce Drive, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1083-8791(03)00229-5DOI Listing
October 2003